Fasoracetam (also known as NS-105 or 5-oxo-D-proline piperidine amide) is a synthetic nootropic compound belonging to the racetam family. Developed in the 1990s, it has been investigated for its potential to enhance cognitive function, improve memory, and exert anxiolytic (anti-anxiety) effects. Unlike some other racetams, Fasoracetam primarily interacts with specific neurotransmitter systems, particularly those involving GABA and acetylcholine, in unique ways. It has been explored for its therapeutic potential in conditions such as Attention Deficit Hyperactivity Disorder (ADHD). As an investigational compound, human studies are limited, and its availability is primarily through research chemical suppliers, rather than as an FDA-approved drug or dietary supplement. Consumers should be aware that the regulatory status and safety profile of Fasoracetam are not as established as many other compounds. (PubChem)
Deep dive
Tap a section to expand.
Known interactions
Category rule: glp1 × supplement
Note
GLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.
Time oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider.
Category rule: supplement × medication
Note
Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).
Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Frequently asked
Sources referenced
["PubChem", "DrugBank"]
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the supplement category or studied for the same goals.
